Payment overview · 2025
General Payments
$80.00
1 reported records · 1 companies
Healthcare provider profile · identity verified
Jonathan D Bornfreund, D.O.
Allopathic & Osteopathic Physicians|Family Medicine · MYRTLE BEACH, SC · NPI 1689634289
Verified facts
What the public records show
CMS Open Payments records show Jonathan D Bornfreund, D.O. received $80.00 in general payments during 2025 across 1 reported records.
Caris MPI, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Caris MPI, Inc. | Unresolved — no canonical attribution shown | $80.00 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $80.00 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| MI CANCER SEEK Normalized: mi cancer seek |
Device | Caris MPI, Inc. | $80.00 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Rosuvastatin Calcium | Rosuvastatin Calcium | 747 | 208 |
| Amlodipine Besylate | Amlodipine Besylate | 663 | 194 |
| Levothyroxine Sodium | Levothyroxine Sodium | 645 | 163 |
| Atorvastatin Calcium | Atorvastatin Calcium | 632 | 178 |
| Losartan Potassium | Losartan Potassium | 518 | 143 |
| Lisinopril | Lisinopril | 400 | 113 |
| Omeprazole | Omeprazole | 379 | 120 |
| Hydrochlorothiazide | Hydrochlorothiazide | 339 | 113 |
| Metoprolol Succinate | Metoprolol Succinate | 312 | 83 |
| Metformin Hcl | Metformin Hcl | 271 | 81 |
| Ezetimibe | Ezetimibe | 226 | 63 |
| Pantoprazole Sodium | Pantoprazole Sodium | 223 | 71 |
| Valsartan | Valsartan | 223 | 69 |
| Alprazolam | Alprazolam | 215 | 36 |
| Meloxicam | Meloxicam | 213 | 92 |
| Duloxetine Hcl | Duloxetine Hcl | 174 | 60 |
| Zolpidem Tartrate | Zolpidem Tartrate | 166 | 40 |
| Furosemide | Furosemide | 161 | 70 |
| Tamsulosin Hcl | Tamsulosin Hcl | 152 | 45 |
| Allopurinol | Allopurinol | 148 | 44 |
| Fluticasone Propionate | Fluticasone Propionate | 148 | 69 |
| Metoprolol Tartrate | Metoprolol Tartrate | 131 | 40 |
| Carvedilol | Carvedilol | 127 | 32 |
| Montelukast Sodium | Montelukast Sodium | 126 | 38 |
| Irbesartan | Irbesartan | 125 | 36 |
| Escitalopram Oxalate | Escitalopram Oxalate | 124 | 38 |
| Ozempic | Semaglutide | 120 | 33 |
| Gabapentin | Gabapentin | 119 | 46 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 111 | 31 |
| Finasteride | Finasteride | 106 | 34 |
| Clopidogrel | Clopidogrel Bisulfate | 105 | 31 |
| Hydralazine Hcl | Hydralazine Hcl | 103 | 29 |
| Mounjaro | Tirzepatide | 101 | 22 |
| Azelastine Hcl | Azelastine Hcl | 100 | 41 |
| Famotidine | Famotidine | 99 | 35 |
| Trazodone Hcl | Trazodone Hcl | 97 | 35 |
| Pravastatin Sodium | Pravastatin Sodium | 90 | 27 |
| Topiramate | Topiramate | 89 | 18 |
| Fenofibrate | Fenofibrate Nanocrystallized | 87 | 28 |
| Fluoxetine Hcl | Fluoxetine Hcl | 86 | 24 |
| Sertraline Hcl | Sertraline Hcl | 85 | 24 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 81 | 36 |
| Doxycycline Hyclate | Doxycycline Hyclate | 80 | 73 |
| Glipizide Er | Glipizide | 80 | 26 |
| Potassium Chloride | Potassium Chloride | 80 | 28 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 79 | suppressed |
| Simvastatin | Simvastatin | 78 | 23 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 78 | 22 |
| Eliquis | Apixaban | 74 | 22 |
| Metformin Hcl Er | Metformin Hcl | 74 | 25 |
| Prednisone | Prednisone | 73 | 56 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 71 | 20 |
| Bupropion Xl | Bupropion Hcl | 68 | 23 |
| Memantine Hcl | Memantine Hcl | 61 | 16 |
| Atenolol | Atenolol | 58 | 15 |
| Diclofenac Sodium | Diclofenac Sodium | 57 | 24 |
| Spironolactone | Spironolactone | 54 | 19 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 53 | 13 |
| Celecoxib | Celecoxib | 52 | 19 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 51 | 45 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 49 | 24 |
| Oxycodone Hcl | Oxycodone Hcl | 47 | suppressed |
| Diazepam | Diazepam | 45 | suppressed |
| Azithromycin | Azithromycin | 42 | 36 |
| Glipizide | Glipizide | 42 | 12 |
| Alendronate Sodium | Alendronate Sodium | 41 | 14 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 40 | 21 |
| Pioglitazone Hcl | Pioglitazone Hcl | 40 | 12 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 40 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 39 | 21 |
| Clonazepam | Clonazepam | 38 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 37 | 12 |
| Propranolol Hcl | Propranolol Hcl | 36 | 11 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 34 | 32 |
| Synthroid | Levothyroxine Sodium | 34 | suppressed |
| Dutasteride | Dutasteride | 33 | suppressed |
| Xarelto | Rivaroxaban | 33 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 32 | 11 |
| Amoxicillin | Amoxicillin | 32 | 30 |
| Valacyclovir | Valacyclovir Hcl | 32 | 18 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 32 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 31 | suppressed |
| Lorazepam | Lorazepam | 31 | 11 |
| Chlorthalidone | Chlorthalidone | 28 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 28 | suppressed |
| Temazepam | Temazepam | 28 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 27 | 12 |
| Rybelsus | Semaglutide | 27 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 27 | suppressed |
| Estradiol | Estradiol | 26 | 11 |
| Glimepiride | Glimepiride | 26 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 25 | 13 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 25 | suppressed |
| Nitroglycerin | Nitroglycerin | 25 | 12 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 25 | suppressed |
| Ketoconazole | Ketoconazole | 24 | 17 |
| Lansoprazole | Lansoprazole | 24 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 24 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 24 | 21 |
| Donepezil Hcl | Donepezil Hcl | 23 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 23 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 22 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 22 | 12 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 21 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 21 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 21 | suppressed |
| Januvia | Sitagliptin Phosphate | 20 | suppressed |
| Pregabalin | Pregabalin | 20 | suppressed |
| Premarin | Estrogens, Conjugated | 20 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 20 | suppressed |
| Testosterone | Testosterone | 20 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 20 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 19 | suppressed |
| Acyclovir | Acyclovir | 18 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 18 | suppressed |
| Gemfibrozil | Gemfibrozil | 18 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 17 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 17 | 16 |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 16 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 16 | 11 |
| Lovastatin | Lovastatin | 16 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 16 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 15 | suppressed |
| Lubiprostone | Lubiprostone | 15 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 14 | suppressed |
| Lactulose | Lactulose | 14 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 14 | suppressed |
| Novolog Flexpen | Insulin Aspart | 14 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 14 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 14 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 14 | suppressed |
| Fenofibrate | Fenofibrate | 13 | suppressed |
| Halobetasol Propionate | Halobetasol Propionate | 13 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Metolazone | Metolazone | 13 | suppressed |
| Ondansetron Odt | Ondansetron | 13 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 13 | suppressed |
| Prempro | Estrogen,con/M-Progest Acet | 13 | suppressed |
| Clorazepate Dipotassium | Clorazepate Dipotassium | 12 | suppressed |
| Naproxen | Naproxen | 12 | suppressed |
| Nifedipine Er | Nifedipine | 12 | suppressed |
| Nystatin | Nystatin | 12 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 12 | suppressed |
| Trulicity | Dulaglutide | 12 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 11 | suppressed |
| Ibuprofen | Ibuprofen | 11 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 11 | suppressed |
| Primidone | Primidone | 11 | suppressed |
| Telmisartan | Telmisartan | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $80.00 · 1 records | Caris MPI, Inc. | MI CANCER SEEK | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error